Marshall Wace’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.47M Sell
31,011
-24,241
-44% -$1.25M ﹤0.01% 2015
2026
Q1
$3.27M Buy
+55,252
New +$3.58M ﹤0.01% 1526
2024
Q3
Sell
-123,920
Closed -$8.53M 2842
2024
Q2
$8.53M Buy
123,920
+7,696
+7% +$521K 0.01% 805
2024
Q1
$8.43M Buy
116,224
+24,474
+27% +$1.64M 0.01% 805
2023
Q4
$5.62M Buy
91,750
+66,941
+270% +$3.97M 0.01% 872
2023
Q3
$1.42M Buy
+24,809
New +$1.5M ﹤0.01% 1372
2022
Q2
Sell
-81,151
Closed -$4.3M 3736
2022
Q1
$4.3M Buy
+81,151
New +$4.69M 0.01% 1483
2020
Q4
Sell
-38,058
Closed -$1.39M 2102
2020
Q3
$1.39M Buy
+38,058
New +$1.42M 0.01% 908
2020
Q2
Sell
-23,296
Closed -$854K 1856
2020
Q1
$854K Buy
+23,296
New +$905K 0.01% 841
2019
Q2
Sell
-1,149
Closed -$34K 1720
2019
Q1
$34K Hold
1,149
﹤0.01% 1581
2018
Q4
$35K Buy
+1,149
New +$41.9K ﹤0.01% 1488
2017
Q1
Sell
-40,362
Closed -$2.1M 631
2016
Q4
$2.1M Buy
40,362
+33,541
+492% +$1.62M 0.01% 622
2016
Q3
$329K Sell
6,821
-28,933
-81% -$1.46M ﹤0.01% 847
2016
Q2
$1.98M Buy
+35,754
New +$1.97M 0.02% 590
2014
Q3
Sell
-216,343
Closed -$7.33M 995
2014
Q2
$7.33M Buy
+216,343
New +$6.93M 0.11% 219

Other funds holding PBH

Marshall Wace's PBH Position: Q2 2026 in Review

Marshall Wace reduced its Prestige Consumer Healthcare (PBH) stake by 44% in Q2 2026, selling an estimated $1.25M and leaving 31,011 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2015.

Marshall Wace first reported a position in PBH in Q2 2014 and has held it in 15 quarters since. The position peaked at $8.53M in Q2 2024. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Marshall Wace held 31,011 shares of Prestige Consumer Healthcare worth $1.47M as of Q2 2026.
  • Marshall Wace sold 24,241 Prestige Consumer Healthcare shares in Q2 2026, an estimated $1.25M.
  • Prestige Consumer Healthcare made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2015 holding.
  • Marshall Wace first reported a position in Prestige Consumer Healthcare in Q2 2014 and has held it in 15 quarters since.
  • Marshall Wace's Prestige Consumer Healthcare position peaked at $8.53M in Q2 2024.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.